{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:08:23Z","timestamp":1778335703344,"version":"3.51.4"},"reference-count":11,"publisher":"Japan Society of Histochemistry & Cytochemistry","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Histochem. Cytochem.","Acta Histochemica et Cytochemica","Acta Histochem. Cytochem"],"published-print":{"date-parts":[[2019,12,27]]},"DOI":"10.1267\/ahc.19031","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T22:04:05Z","timestamp":1577225045000},"page":"101-106","source":"Crossref","is-referenced-by-count":7,"title":["Localization and Accumulation Studies of Dacomitinib in Rat Intestines and Skin by Immunohistochemistry"],"prefix":"10.1267","volume":"52","author":[{"given":"Yutaro","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Saita","sequence":"additional","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuki","family":"Oka","sequence":"additional","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroto","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Shin","sequence":"additional","affiliation":[{"name":"Applied Life Science Department, Faculty of Biotechnology and Life Science, Sojo University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"334","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ding, P. N., Lord, S. J., Gebski, V., Links, M., Bray, V., Gralla, R. J., Yang, J. C. and Lee, C. K. (2017) Risk of treatment-related toxicities from EGFR tyrosine kinase inhibitors: a meta-analysis of clinical trials of gefitinib, erlotinib, and afatinib in advanced EGFR-mutated non-small cell lung cancer. J. Thorac. Oncol. 12; 633\u2013643.","DOI":"10.1016\/j.jtho.2016.11.2236"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Gajiwala, K. S., Feng, J., Ferre, R., Ryan, K., Brodsky, O., Weinrich, S., Kath, J. C. and Stewart, A. (2013) Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure 21; 209\u2013219.","DOI":"10.1016\/j.str.2012.11.014"},{"key":"3","unstructured":"3 Green, M. R., Basketter, D. A., Couchaman, J. R. and Rees, D. A. (1983) Distribution and number of epidermal factor receptors in skin is related to epithelial cell growth. Dev. Biol. 100; 506\u2013512."},{"key":"4","unstructured":"4 Ou, S. H. (2012) Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence. Crit. Rev. Oncol. Hematol. 83; 407\u2013421."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Park, K., Tan, E. H., O\u2019Byrne, K., Zhang, L., Boyer, M., Mok, T., Hirsh, V., Yang, J. C., Lee, K. H., Lu, S., Shi, Y., Kim, S. W., Laskin, J., Kim, D. W., Arvis, C. D., K\u00f6lbeck, K., Laurie, S. A., Tsai, C. M., Shahidi, M., Kim, M., Massey, D., Zazulina, V. and Paz-Ares, L. (2016) Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Lancet Oncol. 17; 577\u2013589.","DOI":"10.1016\/S1470-2045(16)30033-X"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Qu, X., Sandmann, T., Jr. Frierson, H., Fu, L., Fuentes, E., Walter, K., Okrah, K., Rumpel, C., Moskaluk, C., Lu, S., Wang, Y., Bourgon, R., Penuel, E., Pirzkall, A., Amler, L., Lackner, M. R., Tabernero, J., Hampton, G. M. and Kabbarah, O. (2016) Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter. Oncogene 35; 6403\u20136415.","DOI":"10.1038\/onc.2016.170"},{"key":"7","unstructured":"7 Sogawa, R., Saita, T., Yamamoto, Y., Kimura, S., Narisawa, Y., Kimura, S. and Shin, M. (2019) Development of a competitive enzyme-linked immunosorbent assay for therapeutic drug monitoring of afatinib. J. Pharm. Anal. 9; 49\u201354."},{"key":"8","unstructured":"9 Tani, Y., Hatanaka, Y. and Hashizume, K. (2005) Development of Precise Pharmocodiagnostic (PharmDx) Tests for Molecular Targeted Therapies. Acta Histochem. Cytochem. 38; 209\u2013216."},{"key":"9","unstructured":"10 Van, Sebille, Y. Z. A., Gibson, R. J., Wardill, H. R., Secombe, K. R., Ball, I. A., Keefe, D. M. K., Finnie, J. W. and Bowen, J. M. (2017) Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats. Int. J. Cancer 140; 2820\u20132829."},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Wang, J. I., Li-Chan, X. X., Atherton, J., Deng, L., Espina, R., Yu, L., Horwatt, P., Ross, S., Lockhead, S., Ahmad, S., Chandrasekaran, A., Oganesian, A., Scatina, J., Mutlib, A. and Talaat, R. (2010) Characterization of HKI-272 covalent binding to human serum albumin. Drug Metab. Dispos. 38; 1083\u20131093.","DOI":"10.1124\/dmd.110.032292"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Wu, Y. L., Cheng, Y., Zhou, X., Lee, K. H., Nakagawa, K., Niho, S., Tsuji, F., Linke, R., Rosell, R., Corral, J., Migliorino, M. R., Pluzanski, A., Sbar, E. I., Wang, T., White, J. L., Nadanaciva, S., Sandin, R. and Mok, T. S. (2017) Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial. Lancet Oncol. 18; 1454\u20131466.","DOI":"10.1016\/S1470-2045(17)30608-3"}],"container-title":["ACTA HISTOCHEMICA ET CYTOCHEMICA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/52\/6\/52_19031\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,25]],"date-time":"2020-01-25T04:10:10Z","timestamp":1579925410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ahc\/52\/6\/52_19031\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,27]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1267\/ahc.19031","relation":{},"ISSN":["0044-5991","1347-5800"],"issn-type":[{"value":"0044-5991","type":"print"},{"value":"1347-5800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,27]]}}}